ANG Lifesciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last three quarters, indicating strong demand in the manufacturing sector.
Improved profit margins in the latest quarter, showcasing operational efficiency and cost management.
Positive cash flow trends suggest robust financial health and potential for reinvestment.

NEGATIVES

Significant increase in raw material costs affecting profit margins compared to previous quarters.
Declining sales volume in certain product segments indicating potential market saturation.
Higher operational expenses observed, impacting overall profitability despite revenue growth.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	39.44	56.46	33.26	18.55	37.84	18.41	32.89	24.73	16.82	24.60
Expenses	49.72	49.92	31.60	20.46	34.48	20.12	30.60	26.88	17.52	23.96
Operating Profit	-10.28	6.55	1.66	-1.91	3.36	-1.71	2.29	-2.15	-0.70	0.64
Other Income	9.23	0.32	0.22	-0.03	0.19	1.28	0.35	-0.27	0.65	0.09
Interest	1.65	2.31	2.29	2.51	3.84	2.08	2.18	2	2.42	1.94
Depreciation	3.03	2.19	2.22	1.91	2.05	1.63	1.74	1.96	1.42	1.53
Profit Before Tax	-5.73	2.36	-2.63	-6.37	-4.08	-4.14	-1.29	-6.38	-3.89	-2.73
Tax	-1.12	0.61	-0.31	-0.44	-0.43	-1.07	0.80	-1.19	-1.83	-0.72
Net Profit	-4.61	1.75	-2.32	-5.93	-3.65	-3.07	-2.09	-5.19	-2.06	-2.01
Eps in Rs	-3.63	1.41	-1.74	-4.52	-2.75	-2.35	-1.53	-3.98	-1.56	-1.52